Clinical Trials

Phase 3 Active not recruiting

Carcinoma, Non-Small-Cell Lung

NCT03456076 2026-01-30

A Study Comparing Adjuvant Alectinib Versus Adjuvant Platinum-Based Chemotherapy in Patients With ALK Positive Non-Small Cell Lung Cancer

257 enrolled 14 charts 2 FDA

Phase 3 Active not recruiting

Carcinoma, Non-Small-Cell Lung

NCT06564844 2026-01-27

TROPION-Lung12

24 enrolled

Adenocarcinoma, Carcinoma, Non-Small-Cell Lung

NCT06908304 2026-01-12

A Phase III Study With THIO + Cemiplimab vs Chemotherapy as 3rd Line Treatment in Advanced/Metastatic NSCLC

Phase 3 Recruiting

300 enrolled

Adenocarcinoma, Carcinoma, Non-Small-Cell Lung, Carcinoma, Squamous Cell, Carcinoma, Large Cell

NCT02998528 2026-01-06

CheckMate 816

505 enrolled 17 charts 2 FDA

Carcinoma, Non-Small-Cell Lung

NCT02489903 2025-03-17

RRx-001 in Lung Cancer, Ovarian Cancer and Neuroendocrine Tumors Prior to Re-administration of Platinum Based Doublet Regimens (QUADRUPLE THREAT)

EndocrineGynecologicNETThoracic

139 enrolled 14 charts

Carcinoma, Ovarian Epithelial, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Carcinoma, Small Cell, Neuroendocrine Tumors

NCT02892123 2024-11-27

Trial of ZW25 (Zanidatamab) in Patients With Advanced HER2-expressing Cancers

BreastGastrointestinalGynecologicThoracic

279 enrolled

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Neoplasms, Ovarian Neoplasms, Stomach Neoplasms

NCT03191786 2024-10-23

IPSOS

453 enrolled 20 charts

Carcinoma, Non-Small-Cell Lung

NCT05487391 2024-10-15

A Study of QL1706 Combined With Platinum-containing Chemotherapy in Adjuvant Treatment of Stage II-IIIB Non-small Cell Lung Cancer After Complete Surgical Resection.

Phase 3 Recruiting

632 enrolled

Carcinoma, Non-Small-Cell Lung

NCT02352948 2024-07-26

ARCTIC

597 enrolled 23 charts

Non - Small Cell Lung Cancer NSCLC

NCT05583188 2024-07-19

VIGOR

Phase 4 Terminated

5 enrolled

Lung Diseases, Lung Neoplasms, Thoracic Neoplasms

NCT03891173 2022-08-12

A Study of L-DOS47 in Combination With Vinorelbine/Cisplatin in Lung Adenocarcinoma

Phase 2 Terminated

9 enrolled

Adenocarcinoma of Lung

NCT03770299 2022-03-24

CheckMate 9TN

Phase 2 Withdrawn

Carcinoma, Non-Small-Cell Lung

NCT02448797 2021-07-20

EVIDENCE

Phase 3 Unknown

320 enrolled

Carcinoma, Non-Small-Cell Lung

NCT02610140 2020-11-04

Phase II Anetumab Ravtansine as 2nd Line Treatment for Malignant Pleural Mesothelioma (MPM)

Other solid neoplasmThoracic

248 enrolled 23 charts

Mesothelioma

NCT00054197 2020-10-05

Polyglutamate Paclitaxel Compared With Gemcitabine or Vinorelbine in Treating Patients With Advanced or Recurrent Non-Small Cell Lung Cancer

Phase 3 Terminated

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT02117024 2020-02-05

A Phase 2 Study of Viagenpumatucel-L (HS-110) in Patients With Non-Small Cell Lung Cancer

Phase 2 Terminated

66 enrolled 17 charts

Carcinoma, Non-Small-Cell Lung, Neoplasms

NCT02619929 2018-08-29

StepUp

Completed

108 enrolled

BreastThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung

NCT00455572 2017-05-15

Cancer Immunotherapy GSK1572932A as Adjuvant Therapy for Patients With Tumor-antigen-positive Non-Small Cell Lung Cancer

Phase 1 Terminated

71 enrolled

Carcinoma, Non-Small-Cell Lung

NCT00842712 2017-01-13

CERTO

232 enrolled 17 charts

Metatropic dwarfism, Carcinoma, Non-Small-Cell Lung

NCT00773188 2016-11-02

A Feasibility Trial of Avastin (Bevacizumab) in Combination With Concomitant Chemoradiation (Cisplatin and Vinorelbine) in Patients With Locally Advanced Non-Squamous Non-Small Cell Lung Cancer.

6 enrolled

Other solid neoplasmThoracic

Non-Squamous Non-Small Cell Lung Cancer

NCT00597116 2016-10-10

An Efficacy and Safety Study With Vandetanib to Treat Inoperable or Relapsed Malignant Mesothelioma

Phase 2 Terminated

25 enrolled 8 charts

Mesothelioma, Recurrence

NCT00683514 2016-10-04

Oral Chemotherapy And Platinum With Radiotherapy Followed Or Not By Consolidation With The Same Chemotherapy In Locally Advanced Non Small Cell Lung Cancer

201 enrolled

NSCLC

NCT00496275 2016-08-26

Phase I Combination With Vinorelbine or Gemcitabine Plus Cisplatin in Locally Advanced or Metastatic NSCLC

17 enrolled

Carcinoma, Non-Small-Cell Lung

NCT00686959 2016-06-28

PROCLAIM

598 enrolled 21 charts

Carcinoma, Non-Small-Cell Lung

NCT01109524 2015-12-24

Safety Study of Cetuximab in Combination With Cisplatin and Vinorelbine to Treat Advanced Non-small Cell Lung Cancer

72 enrolled 15 charts

Carcinoma, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT01196078 2015-07-27

A Study of Tarceva (Erlotinib) in Elderly Patients With Advanced Non-Small Cell Lung Cancer

Phase 4 Completed

114 enrolled 15 charts

Carcinoma, Non-Small-Cell Lung

NCT01843647 2015-07-15

Neoadjuvant Therapy of Icotinib in Epidermal Growth Factor Receptor Mutated NSCLC Patients

Phase 2 Unknown

100 enrolled

Carcinoma, Non-Small-Cell Lung

NCT00148798 2014-06-25

FLEX

1,861 enrolled 15 charts

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00055887 2013-05-10

Chemotherapy and Radiation Therapy With or Without Efaproxiral in Treating Patients With Stage III Non-Small Cell Lung Cancer

Phase 3 Withdrawn

Adenocarcinoma of Lung, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT01839032 2013-04-24

Oral Vinorelbine as Induction Chemotherapy Followed Concomitant Chemoradiotherapy

70 enrolled

Lung Neoplasms

NCT00042315 2012-05-23

A Double-Blind, Randomized, Placebo-Controlled, Multicenter, Phase III Study of Tariquidar + Vinorelbine as First-Line Therapy in Non-Small Cell Lung Cancer (NSCLC)

Phase 3 Terminated

490 enrolled

Carcinoma, Non-Small-Cell Lung

NCT00432562 2012-02-23

A Bioequivalence Study of Vinorelbine Tartrate Injectable Emulsion in Patients With Advanced Cancer.

31 enrolled 17 charts

BreastLymphoidThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Lymphoma, Non-Hodgkin

NCT00271271 2009-12-07

GON

40 enrolled

Carcinoma, Non-Small-Cell Lung

NCT00256711 2009-04-23

Phase II Iressa Versus Vinorelbine (INVITE)

192 enrolled

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00333294 2007-12-19

Phase II Iressa + Irradiation Followed by Chemo in NSCLC

50 enrolled